These data resemble the results from MCF10DCIS.com xenografts and provide clinical support for the presence of the novel subgroup coexpressing basal markers and Her2/neu, and for a novel link between comedo-DCIS and basal-like breast cancer. Here, ERBB2 is linked to breast carcinoma.